Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
Public ClinicalTrials.gov record NCT02970942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
This Trial is Conducted Globally. The Aim of This Trial is to Investigate Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis
Study identification
- NCT ID
- NCT02970942
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 320 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016 (Actual)
- Primary completion
- Feb 13, 2020 (Actual)
- Completion
- Mar 19, 2020 (Actual)
- Last update posted
- Nov 16, 2021
2016 – 2020
United States locations
- U.S. sites
- 39
- U.S. states
- 17
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35233 | — |
| Novo Nordisk Investigational Site | Chandler | Arizona | 85224 | — |
| Novo Nordisk Investigational Site | Tucson | Arizona | 85712 | — |
| Novo Nordisk Investigational Site | Coronado | California | 92118 | — |
| Novo Nordisk Investigational Site | Costa Mesa | California | 92627 | — |
| Novo Nordisk Investigational Site | La Mesa | California | 91942 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057 | — |
| Novo Nordisk Investigational Site | Northridge | California | 91325 | — |
| Novo Nordisk Investigational Site | Panorama City | California | 91402 | — |
| Novo Nordisk Investigational Site | Rialto | California | 92377 | — |
| Novo Nordisk Investigational Site | Boca Raton | Florida | 33434 | — |
| Novo Nordisk Investigational Site | Gainesville | Florida | 32610 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32207 | — |
| Novo Nordisk Investigational Site | Lakewood Rch | Florida | 34211 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33014 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33136 | — |
| Novo Nordisk Investigational Site | Ocoee | Florida | 34761 | — |
| Novo Nordisk Investigational Site | Sarasota | Florida | 34240 | — |
| Novo Nordisk Investigational Site | Monroe | Louisiana | 71201 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21202 | — |
| Novo Nordisk Investigational Site | Detroit | Michigan | 48202 | — |
| Novo Nordisk Investigational Site | Rochester | Minnesota | 55905 | — |
| Novo Nordisk Investigational Site | Omaha | Nebraska | 68198 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89106 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89109 | — |
| Novo Nordisk Investigational Site | Manhasset | New York | 11030 | — |
| Novo Nordisk Investigational Site | Danville | Pennsylvania | 17822-2111 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| Novo Nordisk Investigational Site | Hermitage | Tennessee | 37076 | — |
| Novo Nordisk Investigational Site | Austin | Texas | 78731 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-9302 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77030 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77058 | — |
| Novo Nordisk Investigational Site | Rollingwood | Texas | 78746 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Burlington | Vermont | 05401 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23249 | — |
| Novo Nordisk Investigational Site | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02970942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2021 · Synced Oct 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02970942 live on ClinicalTrials.gov.